Tuesday, May 17, 2016

BRIEF-Essetifin announces acquisition of additional shares of Fennec Pharma and filing of its early warning report

* Acquired through second closing of non-brokered private

placement 1.5 million common shares in capital of fennec

pharmaceuticals

Read more

No comments:

Post a Comment